Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutemetamol F 18 Brain Uptake in Japanese Subjects
NCT02813070Phase 2Completed
- Sponsor
- GE HealthCare
- Start
- Oct 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of flutemetamol in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by GE HealthCare. Started Oct 2012; status: completed.
02
Drugs
flutemetamol
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT02813070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02813070.